{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T17:19:16Z","timestamp":1778174356232,"version":"3.51.4"},"reference-count":74,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:00:00Z","timestamp":1589414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0232753","type":"journal-article","created":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T18:17:02Z","timestamp":1589480222000},"page":"e0232753","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["A non-stationary Markov model for economic evaluation of grass pollen allergoid immunotherapy"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5330-2403","authenticated-orcid":true,"given":"Massimo","family":"Bilancia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Pasculli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo","family":"Di Bona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,5,14]]},"reference":[{"issue":"4","key":"pone.0232753.ref001","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/all.13317","article-title":"EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis","volume":"73","author":"G Roberts","year":"2018","journal-title":"Allergy"},{"issue":"11","key":"pone.0232753.ref002","first-page":"985","article-title":"Treatment of Allergic Rhinitis","volume":"92","author":"DKC Sur","year":"2015","journal-title":"Am Fam Physician"},{"issue":"7","key":"pone.0232753.ref003","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/cea.12953","article-title":"BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007)","volume":"47","author":"GK Scadding","year":"2017","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"pone.0232753.ref004","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.anai.2017.08.012","article-title":"Treatment of seasonal allergic rhinitis: An evidence-based focused 2017 guideline update","volume":"119","author":"MS Dykewicz","year":"2017","journal-title":"Annals of Allergy, Asthma & Immunology"},{"issue":"2","key":"pone.0232753.ref005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/0194599814562166","article-title":"Clinical practice guideline: allergic rhinitis executive summary","volume":"152","author":"MD Seidman","year":"2015","journal-title":"Otolaryngology\u2013Head and Neck Surgery"},{"issue":"3","key":"pone.0232753.ref006","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1586\/eci.10.15","article-title":"The link between allergic rhinitis and asthma: the united airways disease","volume":"6","author":"E Compalati","year":"2010","journal-title":"Expert Review of Clinical Immunology"},{"issue":"5","key":"pone.0232753.ref007","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2500\/aap.2014.35.3794","article-title":"Allergic rhinitis and asthma: Epidemiology and common pathophysiology","volume":"35","author":"DA Khan","year":"2014","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"pone.0232753.ref008","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/ACI.0000000000000375","article-title":"Seasonal Allergic Rhinitis: A focused systematic review and practice parameter update","volume":"17","author":"DV Wallace","year":"2017","journal-title":"Current opinion in allergy and clinical immunology"},{"issue":"12","key":"pone.0232753.ref009","doi-asserted-by":"crossref","first-page":"876","DOI":"10.7326\/M17-2203","article-title":"Pharmacologic Treatment of Seasonal Allergic Rhinitis: Synopsis of Guidance From the 2017 Joint Task Force on Practice Parameters","volume":"167","author":"DV Wallace","year":"2017","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"pone.0232753.ref010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4168\/aair.2016.8.3.191","article-title":"Allergen Immunotherapy: Past, Present, and Future","volume":"8","author":"M Jutel","year":"2016","journal-title":"Allergy, Asthma & Immunology Research"},{"issue":"1","key":"pone.0232753.ref011","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12948-018-0085-8","article-title":"A critical appraisal on AIT in childhood asthma","volume":"16","author":"M Ferrando","year":"2018","journal-title":"Clinical and Molecular Allergy"},{"issue":"12","key":"pone.0232753.ref012","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/all.13208","article-title":"Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis","volume":"72","author":"S Dhami","year":"2017","journal-title":"Allergy"},{"issue":"7","key":"pone.0232753.ref013","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/alr.21946","article-title":"The effect of allergen immunotherapy in the onset of new sensitizations: a meta-analysis","volume":"7","author":"G Di Lorenzo","year":"2017","journal-title":"International Forum of Allergy & Rhinology"},{"issue":"3","key":"pone.0232753.ref014","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jaci.2014.07.024","article-title":"Comparative efficacy and safety of subcutaneous versus sublingual immunotherapy","volume":"134","author":"CS Bauer","year":"2014","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"pone.0232753.ref015","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jaci.2015.04.047","article-title":"International consensus on allergy immunotherapy","volume":"136","author":"M Jutel","year":"2015","journal-title":"The Journal of allergy and clinical immunology"},{"issue":"2","key":"pone.0232753.ref016","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jaci.2005.11.014","article-title":"Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis","volume":"117","author":"AJ Frew","year":"2006","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"2","key":"pone.0232753.ref017","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jaci.2015.12.1298","article-title":"Sublingual or subcutaneous immunotherapy for allergic rhinitis?","volume":"137","author":"SR Durham","year":"2016","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"3","key":"pone.0232753.ref018","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40521-018-0176-2","article-title":"Duration of Allergen Immunotherapy for Long-Term Efficacy in Allergic Rhinoconjunctivitis","volume":"5","author":"M Penagos","year":"2018","journal-title":"Current Treatment Options in Allergy"},{"issue":"5","key":"pone.0232753.ref019","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMcp1412282","article-title":"Allergic Rhinitis","volume":"372","author":"LM Wheatley","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"pone.0232753.ref020","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/jama.2016.21040","article-title":"Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial","volume":"317","author":"GW Scadding","year":"2017","journal-title":"JAMA"},{"issue":"8","key":"pone.0232753.ref021","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/jamainternmed.2015.2840","article-title":"Efficacy of Grass Pollen Allergen Sublingual Immunotherapy Tablets for Seasonal Allergic Rhinoconjunctivitis","volume":"175","author":"D Di Bona","year":"2015","journal-title":"JAMA Internal Medicine"},{"issue":"5","key":"pone.0232753.ref022","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jaci.2012.08.012","article-title":"Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: A meta-analysis\u2013based comparison","volume":"130","author":"D Di Bona","year":"2012","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"27","key":"pone.0232753.ref023","first-page":"vixi1","article-title":"A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis","volume":"17","author":"A Meadows","year":"2013","journal-title":"Health technology assessment (Winchester, England)"},{"issue":"5","key":"pone.0232753.ref024","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1183\/09031936.04.00013904","article-title":"Prevalence and rate of diagnosis of allergic rhinitis in Europe","volume":"24","author":"V Bauchau","year":"2004","journal-title":"The European respiratory journal"},{"issue":"1","key":"pone.0232753.ref025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12948-016-0049-9","article-title":"Burden of allergic respiratory disease: a systematic review","volume":"14","author":"A Linneberg","year":"2016","journal-title":"Clinical and Molecular Allergy"},{"issue":"1","key":"pone.0232753.ref026","first-page":"22","article-title":"A cost of illness study of allergic rhinitis in the United States","volume":"99","author":"DC Malone","year":"1997","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"10","key":"pone.0232753.ref027","first-page":"517","article-title":"Direct and indirect costs associated with respiratory allergic diseases in Italy. A probabilistic cost of illness study","volume":"106","author":"A Marcellusi","year":"2015","journal-title":"Recenti Progressi in Medicina"},{"key":"pone.0232753.ref028","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision Modelling for Health Economic Evaluation","author":"A Briggs","year":"2006"},{"issue":"1","key":"pone.0232753.ref029","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev-statistics-031017-100404","article-title":"Statistical Modeling for Health Economic Evaluations","volume":"5","author":"G Baio","year":"2018","journal-title":"Annual Review of Statistics and Its Application"},{"key":"pone.0232753.ref030","doi-asserted-by":"crossref","DOI":"10.1201\/b13099","volume-title":"Bayesian Methods in Health Economics","author":"G Baio","year":"2012"},{"issue":"2","key":"pone.0232753.ref031","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/all.13254","article-title":"Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: A systematic overview","volume":"73","author":"M Asaria","year":"2018","journal-title":"Allergy"},{"key":"pone.0232753.ref032","doi-asserted-by":"crossref","unstructured":"Filipovi\u0107-Pierucci A, Zarca K, Durand-Zaleski I. Markov Models for Health Economic Evaluations: The R Package heemod. 2017. arXiv:1702.03252v2 [stat.AP].","DOI":"10.1016\/j.jval.2016.09.133"},{"issue":"1","key":"pone.0232753.ref033","doi-asserted-by":"crossref","DOI":"10.1186\/s13601-015-0045-z","article-title":"Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany","volume":"5","author":"BG Verheggen","year":"2015","journal-title":"Clinical and Translational Allergy"},{"issue":"9643","key":"pone.0232753.ref034","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(08)61446-4","article-title":"Rhinitis and onset of asthma: a longitudinal population-based study","volume":"372","author":"R Shaaban","year":"2008","journal-title":"The Lancet"},{"issue":"1","key":"pone.0232753.ref035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/00019053-200725010-00002","article-title":"Rates and Probabilities in Economic Modelling","volume":"25","author":"RL Fleurence","year":"2007","journal-title":"PharmacoEconomics"},{"key":"pone.0232753.ref036","unstructured":"ISTAT. Tavole di Mortalit\u00e0 della Popolazione Residente; 2019. http:\/\/dati.istat.it\/Index.aspx?DataSetCode=DCIS_MORTALITA1. Accessed April 26, 2019."},{"issue":"1","key":"pone.0232753.ref037","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/thx.52.1.49","article-title":"Mortality of adults with asthma: a prospective cohort study","volume":"52","author":"E Huovinen","year":"1997","journal-title":"Thorax"},{"issue":"4","key":"pone.0232753.ref038","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1185\/03007995.2011.559538","article-title":"Medication persistence with long-term, specific grass pollen immunotherapy measured by prescription renewal rates","volume":"27","author":"J Sieber","year":"2011","journal-title":"Current Medical Research and Opinion"},{"issue":"2","key":"pone.0232753.ref039","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaci.2013.03.013","article-title":"Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy","volume":"132","author":"MA Kiel","year":"2013","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"pone.0232753.ref040","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2147\/PPA.S70326","article-title":"Patients\u2019 compliance with different administration routes for allergen immunotherapy in Germany","volume":"8","author":"AM Egert-Schmidt","year":"2014","journal-title":"Patient Preference and Adherence"},{"issue":"2","key":"pone.0232753.ref041","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11882-015-0586-1","article-title":"Adherence to Sublingual Immunotherapy","volume":"16","author":"C Incorvaia","year":"2016","journal-title":"Current Allergy and Asthma Reports"},{"issue":"8","key":"pone.0232753.ref042","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1398-9995.2007.01451.x","article-title":"Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study","volume":"62","author":"L Jacobsen","year":"2007","journal-title":"Allergy"},{"issue":"1","key":"pone.0232753.ref043","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/all.13213","article-title":"Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real-world database analysis","volume":"73","author":"S Zielen","year":"2018","journal-title":"Allergy"},{"issue":"2","key":"pone.0232753.ref044","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1067\/mai.2002.121317","article-title":"Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study)","volume":"109","author":"C M\u00f6ller","year":"2002","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"4","key":"pone.0232753.ref045","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jaci.2004.07.012","article-title":"Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis","volume":"114","author":"E Novembre","year":"2004","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"pone.0232753.ref046","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/PPA.S122948","article-title":"Sublingual versus subcutaneous immunotherapy: patient adherence at a large German allergy center","volume":"11","author":"ML Lemberg","year":"2017","journal-title":"Patient preference and adherence"},{"issue":"1","key":"pone.0232753.ref047","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/ldq033","article-title":"Health outcomes in economic evaluation: the QALY and utilities","volume":"96","author":"SJ Whitehead","year":"2010","journal-title":"British Medical Bulletin"},{"key":"pone.0232753.ref048","unstructured":"EMA European Medicines Agency. Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases (CHMP\/EWP\/18504\/2006); 2008."},{"issue":"8","key":"pone.0232753.ref049","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1023\/A:1008860113818","article-title":"Development and preliminary validation of the multiattribute Rhinitis Symptom Utility Index","volume":"7","author":"DA Revicki","year":"1998","journal-title":"Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation"},{"issue":"1","key":"pone.0232753.ref050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-6296(86)90020-2","article-title":"Measurement of health state utilities for economic appraisal","volume":"5","author":"GW Torrance","year":"1986","journal-title":"Journal of Health Economics"},{"key":"pone.0232753.ref051","volume-title":"Applied methods of cost-effectiveness analysis in health care","author":"AM Gray","year":"2010"},{"issue":"12","key":"pone.0232753.ref052","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/all.12518","article-title":"The minimally important difference in the Rhinoconjunctivitis Total Symptom Score in grass-pollen-induced allergic rhinoconjunctivitis","volume":"69","author":"P Devillier","year":"2014","journal-title":"Allergy"},{"issue":"2","key":"pone.0232753.ref053","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"M Borenstein","year":"2010","journal-title":"Research Synthesis Methods"},{"key":"pone.0232753.ref054","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"JP Higgins","year":"2008"},{"issue":"6","key":"pone.0232753.ref055","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jval.2012.05.003","article-title":"Using Health State Utility Values in Models Exploring the Cost-Effectiveness of Health Technologies","volume":"15","author":"R Ara","year":"2012","journal-title":"Value in Health"},{"issue":"5","key":"pone.0232753.ref056","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1524-4733.2009.00509.x","article-title":"Comparison of Different Valuation Methods for Population Health Status Measured by the EQ-5D in Three European Countries","volume":"12","author":"S Bernert","year":"2009","journal-title":"Value in Health"},{"issue":"3","key":"pone.0232753.ref057","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1081-1206(10)60498-X","article-title":"Cost-effectiveness of specific subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma","volume":"101","author":"B Br\u00fcggenj\u00fcrgen","year":"2008","journal-title":"Annals of Allergy, Asthma & Immunology"},{"issue":"1","key":"pone.0232753.ref058","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1524-4733.2009.00660.x","article-title":"Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective: The ISPOR Drug Cost Task Force Report\u2014Part II","volume":"13","author":"LP Garrison","year":"2010","journal-title":"Value in Health"},{"issue":"4","key":"pone.0232753.ref059","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2125.1997.00574.x","article-title":"Pharmacoeconomics: basic concepts and terminology","volume":"43","author":"T Walley","year":"1997","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"2","key":"pone.0232753.ref060","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2006.05.003","article-title":"Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis","volume":"118","author":"R Dahl","year":"2006","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"5","key":"pone.0232753.ref061","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1365-2222.2007.02706.x","article-title":"Cost-effectiveness of grass allergen tablet (GRAZAX) for the prevention of seasonal grass pollen induced rhinoconjunctivitis\u2014a Northern European perspective","volume":"37","author":"C Bachert","year":"2007","journal-title":"Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology"},{"issue":"1","key":"pone.0232753.ref062","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000338998","article-title":"The Cost of Persistent Asthma in Europe: An International Population-Based Study in Adults","volume":"160","author":"S Accordini","year":"2013","journal-title":"International Archives of Allergy and Immunology"},{"issue":"1","key":"pone.0232753.ref063","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00019053-199813010-00001","article-title":"How to Calculate Indirect Costs in Economic Evaluations","volume":"13","author":"B Liljas","year":"1998","journal-title":"PharmacoEconomics"},{"key":"pone.0232753.ref064","unstructured":"ISTAT. Principali Aggregati di Contabilit\u00e0 Nazionale; 2019. http:\/\/dati.istat.it\/Index.aspx?DataSetCode=DCCN_PILN. Accessed May 16, 2019."},{"key":"pone.0232753.ref065","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing; 2019. http:\/\/r-project.org."},{"issue":"2","key":"pone.0232753.ref066","doi-asserted-by":"crossref","first-page":"84","DOI":"10.32614\/RJ-2017-036","article-title":"Discrete Time Markov Chains with R","volume":"9","author":"GA Spedicato","year":"2017","journal-title":"The R Journal"},{"issue":"38","key":"pone.0232753.ref067","doi-asserted-by":"crossref","DOI":"10.3310\/hta4380","article-title":"Bayesian methods in health technology assessment: a review","volume":"4","author":"DJ Spiegelhalter","year":"2000","journal-title":"Health Technology Assessment"},{"issue":"6","key":"pone.0232753.ref068","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1191\/0962280202sm307ra","article-title":"Measuring uncertainty in complex decision analysis models","volume":"11","author":"G Parmigiani","year":"2002","journal-title":"Statistical Methods in Medical Research"},{"issue":"23","key":"pone.0232753.ref069","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1002\/sim.1586","article-title":"Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling","volume":"22","author":"DJ Spiegelhalter","year":"2003","journal-title":"Statistics in Medicine"},{"issue":"1","key":"pone.0232753.ref070","doi-asserted-by":"crossref","first-page":"21240","DOI":"10.3402\/jmahp.v1i0.21240","article-title":"Benefits of probabilistic sensitivity analysis\u2014a review of NICE decisions","volume":"1","author":"E Adalsteinsson","year":"2013","journal-title":"Journal of Market Access & Health Policy"},{"issue":"6","key":"pone.0232753.ref071","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/0962280211419832","article-title":"Probabilistic sensitivity analysis in health economics","volume":"24","author":"G Baio","year":"2015","journal-title":"Statistical methods in medical research"},{"issue":"3","key":"pone.0232753.ref072","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/14737167.2017.1330152","article-title":"Recent amendments to NICE\u2019s value-based assessment of health technologies: implicitly inequitable?","volume":"17","author":"M Paulden","year":"2017","journal-title":"Expert Review of Pharmacoeconomics & Outcomes Research"},{"key":"pone.0232753.ref073","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.orhc.2019.04.001","article-title":"Comparing Markov and non-Markov alternatives for cost-effectiveness analysis: Insights from a cervical cancer case","volume":"21","author":"C del Campo","year":"2019","journal-title":"Operations Research for Health Care"},{"issue":"1-2","key":"pone.0232753.ref074","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0304-4076(94)01612-4","article-title":"A generalization of the Beta distribution with applications","volume":"66","author":"JB McDonald","year":"1995","journal-title":"Journal of Econometrics"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0232753","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T21:07:24Z","timestamp":1722892044000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0232753"}},"subtitle":[],"editor":[{"given":"Muhammad Jami","family":"Husain","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,5,14]]},"references-count":74,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0232753","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,14]]}}}